Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 11 | 2024 | 177 | 2.820 |
Why?
|
| Glucose | 10 | 2021 | 444 | 2.400 |
Why?
|
| Insulin | 8 | 2024 | 687 | 1.240 |
Why?
|
| Pyruvate Carboxylase | 2 | 2021 | 2 | 0.960 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2024 | 28 | 0.940 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2015 | 64 | 0.930 |
Why?
|
| Lactic Acid | 1 | 2024 | 70 | 0.900 |
Why?
|
| Glutathione | 2 | 2021 | 51 | 0.870 |
Why?
|
| Aspartic Acid | 2 | 2020 | 29 | 0.790 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2020 | 2 | 0.710 |
Why?
|
| Urea | 1 | 2020 | 34 | 0.700 |
Why?
|
| Arginine | 1 | 2020 | 113 | 0.660 |
Why?
|
| Inflammation | 1 | 2020 | 1101 | 0.440 |
Why?
|
| Islets of Langerhans | 4 | 2021 | 267 | 0.420 |
Why?
|
| Transcription Factors | 4 | 2013 | 1456 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2012 | 675 | 0.300 |
Why?
|
| Neoplasms | 1 | 2018 | 1234 | 0.300 |
Why?
|
| Animals | 15 | 2024 | 19610 | 0.300 |
Why?
|
| Mice | 12 | 2021 | 10256 | 0.290 |
Why?
|
| Metabolomics | 2 | 2020 | 50 | 0.290 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2013 | 44 | 0.270 |
Why?
|
| Cell Survival | 3 | 2020 | 553 | 0.270 |
Why?
|
| Mice, Knockout | 5 | 2015 | 1988 | 0.250 |
Why?
|
| Isoenzymes | 1 | 2024 | 134 | 0.230 |
Why?
|
| Metabolic Syndrome | 3 | 2020 | 150 | 0.210 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 2 | 2020 | 20 | 0.200 |
Why?
|
| Mitochondria | 3 | 2015 | 333 | 0.200 |
Why?
|
| Oxidative Stress | 2 | 2021 | 280 | 0.200 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 75 | 0.190 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 211 | 0.190 |
Why?
|
| Succinic Acid | 1 | 2021 | 10 | 0.190 |
Why?
|
| Uncoupling Protein 1 | 1 | 2021 | 47 | 0.190 |
Why?
|
| Humans | 12 | 2024 | 59320 | 0.190 |
Why?
|
| Hepatitis | 1 | 2021 | 55 | 0.180 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 304 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 158 | 0.180 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2020 | 21 | 0.180 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 25 | 0.180 |
Why?
|
| Adipocytes, Brown | 1 | 2020 | 45 | 0.170 |
Why?
|
| Antioxidants | 1 | 2021 | 243 | 0.170 |
Why?
|
| Signal Transduction | 2 | 2008 | 2890 | 0.160 |
Why?
|
| Nitric Oxide | 1 | 2020 | 144 | 0.160 |
Why?
|
| Cell Line | 6 | 2020 | 2014 | 0.160 |
Why?
|
| Peptides | 2 | 2020 | 548 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 3189 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2016 | 4 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 52 | 0.130 |
Why?
|
| Male | 7 | 2021 | 27483 | 0.130 |
Why?
|
| Insulinoma | 1 | 2015 | 5 | 0.130 |
Why?
|
| Complex Mixtures | 1 | 2015 | 5 | 0.130 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 23 | 0.120 |
Why?
|
| Adult | 3 | 2021 | 15734 | 0.120 |
Why?
|
| Middle Aged | 3 | 2021 | 16236 | 0.120 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2015 | 13 | 0.120 |
Why?
|
| bcl-Associated Death Protein | 1 | 2015 | 10 | 0.120 |
Why?
|
| Thinness | 1 | 2015 | 39 | 0.120 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2015 | 55 | 0.120 |
Why?
|
| Glutamine | 1 | 2015 | 47 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2016 | 944 | 0.120 |
Why?
|
| Phosphotransferases | 1 | 2014 | 21 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2015 | 90 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 195 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2016 | 2103 | 0.110 |
Why?
|
| Mitochondrial Membranes | 1 | 2012 | 4 | 0.100 |
Why?
|
| Young Adult | 2 | 2020 | 4319 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 209 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 316 | 0.100 |
Why?
|
| Ion Channels | 1 | 2012 | 87 | 0.100 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 99 | 0.100 |
Why?
|
| Adolescent | 2 | 2020 | 5916 | 0.100 |
Why?
|
| Female | 4 | 2021 | 30806 | 0.100 |
Why?
|
| Obesity | 2 | 2020 | 1189 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2012 | 353 | 0.100 |
Why?
|
| Metformin | 1 | 2012 | 67 | 0.090 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2010 | 8 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 255 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2010 | 74 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 533 | 0.090 |
Why?
|
| Estrogen Antagonists | 1 | 2009 | 17 | 0.080 |
Why?
|
| Tamoxifen | 1 | 2009 | 34 | 0.080 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 98 | 0.080 |
Why?
|
| Phosphorylation | 4 | 2014 | 861 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 851 | 0.080 |
Why?
|
| Gene Expression | 1 | 2012 | 808 | 0.080 |
Why?
|
| Transgenes | 1 | 2009 | 175 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2009 | 204 | 0.080 |
Why?
|
| Glucose Intolerance | 2 | 2021 | 88 | 0.070 |
Why?
|
| Aged | 2 | 2020 | 13290 | 0.070 |
Why?
|
| Adipose Tissue, Beige | 1 | 2021 | 3 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2021 | 30 | 0.050 |
Why?
|
| Rats | 2 | 2015 | 1907 | 0.050 |
Why?
|
| Calcineurin | 2 | 2013 | 42 | 0.050 |
Why?
|
| Adipose Tissue, White | 1 | 2021 | 82 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 72 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2020 | 79 | 0.040 |
Why?
|
| Cyclic AMP | 2 | 2013 | 143 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 127 | 0.040 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 70 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 1370 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2020 | 79 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 159 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2020 | 91 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 85 | 0.040 |
Why?
|
| Thermogenesis | 1 | 2020 | 108 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2020 | 100 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2020 | 348 | 0.040 |
Why?
|
| Alberta | 1 | 2016 | 4 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 2062 | 0.030 |
Why?
|
| Glucagon | 1 | 2015 | 34 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 73 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 3 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2016 | 132 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 353 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 397 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 40 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 502 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 475 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 267 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2014 | 136 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 522 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2014 | 106 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2013 | 4 | 0.030 |
Why?
|
| Venoms | 1 | 2013 | 11 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 810 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 31 | 0.030 |
Why?
|
| Genomics | 1 | 2016 | 314 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2012 | 3 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2014 | 152 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 299 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 74 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 919 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 589 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2013 | 595 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 500 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 1205 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 377 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 663 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 846 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2008 | 19 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 1907 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 83 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 659 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 847 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 875 | 0.020 |
Why?
|